Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Romano Kelly A, Consejero. Director active across 3 companies, notably Dorman Products, Inc.. Aggregated, 20 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €282k. Activity tracked since 13 May 2021. The latest transaction was filed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Romano Kelly A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
44 títulos@ 103,03 US$19.5% de su flujoCommon StockSEC:0001209191-21-033031:0
20 de 20 declaraciones
About Romano Kelly A
Romano Kelly A is Administrateur and has made 20 filings in total. Across the 20 recent filings available to us, they span from 2021-05-17 to 2026-02-03, with 281766 EUR in purchases and 0 EUR in sales, and the transaction nature is listed as Attribution. The filings relate to Athira Pharma, Inc., Dorman Products, Inc. and UGI CORP, with top reported amounts of 94722.37170584897 EUR, 93746.24763923424 EUR, 61661.16191963781 EUR, 31636.65736745044 EUR, 5426.200481476842 EUR and 3949.752980023398 EUR.